MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Ariad Pharmaceuticals (NASDAQ:ARIA)
Organization & Developments: Ariad
Parents
Ariad Pharmaceuticals (NASDAQ:ARIA)
Children
2011: Ariad Extends Three Tech Licensing Deals (2011)
2013: Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet (2013)
2013: Ariad may still try for approval of leukemia drug in new patients (2013)
2013: Ariad Pharmaceuticals’ relaunch of its leukemia medication in the U.S. will focus on patients who have not responded to other drugs (2013)
2016: Incyte buys ARIAD Pharma's European business for $140M; ARIAD up 5% premarket - Incyte Corporation (NASDAQ:INCY)
Jumps
*Key People: Ariad
Finance & Acquisitions: Ariad